GNC-30751-18320
4 vaccinations
3 coded responses
52 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 223 / VA
- Registered
- 2021-04-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-12
Registered in v-safe
-
2021-04-12
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-12
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-14
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: FairFree text: LightheadedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-15
- 2021-04-16
-
2021-04-17
Survey response — days 1–6 daily, dose 1MedDRA: Back pain — Feeling: Fair · Fatigue or tirednessFree text: Back painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-18
- 2021-04-19
- 2021-04-26
-
2021-05-03
Survey response — day 21, single doseMedDRA: Anxiety, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Increased anxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Report sent to call center — day 21, single doseGet care from a doctor or other healthcare professional1 call case(s)
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-06-10
- 2021-07-12
- 2021-10-11
-
2021-10-29
Dose 2 — Moderna
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-06
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2022-01-28
- 2022-04-29
-
2022-06-24
Dose 3 — Moderna
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-01
- 2022-07-08
- 2022-07-22
- 2022-07-29
- 2022-08-05
- 2022-09-23
-
2022-10-05
Dose 4 — Pfizer-BioNTech
- 2022-10-05
- 2022-10-06
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-03
- 2022-11-09
- 2022-11-16
- 2023-01-04
- 2023-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-12 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-29 | Moderna | No |
| 3 | 2022-06-24 | Moderna | No |
| 4 | 2022-10-05 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Lightheaded
Systemic reaction (other): Back pain
Release 8 — day 21, single dose
Symptoms: Increased anxiety
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Back pain | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release